Overview

A Study to Determine the Efficacy and Safety of Cabergoline for the Treatment of Patients With RLS

Status:
Completed
Trial end date:
2004-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of cabergoline compared with levodopa in the treatment of patients with RLS.
Phase:
Phase 3
Details
Lead Sponsor:
Pfizer
Treatments:
Cabergoline
Levodopa